I was reading my google alerts today and Biomarin published on  2-8-10.  This is the company that is going into Phase I trials for up regulating utrophin.  This sounds like the changed their strategy to rare cancers.  Please comment if you are familiar with this pharma.  Our son has a duplication and the utrophin research is about the only thing that seems do-able for him besides other things like viagra, non steroid drugs, etc.  Thanks.


Views: 17

Reply to This

Replies to This Discussion

I think I figured it out. Biomarin bought another pharma that is into rare cancer meds. Sorry if I caused alarm. Char
Thanks for the clarification Char. I also got really scared.

THey are already in phase 1....started just after the Disney Marathon (the week after),, single site on healthy individuals. Phase I results scheduled to be announced at the end of this year...

Reply to Discussion


Need help using this community site? Visit Ning's Help Page.



© 2020   Created by PPMD.   Powered by

Badges  |  Report an Issue  |  Privacy Policy  |  Terms of Service